Fingolimod potentiates the effects of sunitinib malate in a rat breast cancer model. [electronic resource]
Producer: 20121119Description: 31-40 p. digitalISSN:- 1573-7217
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Aorta, Thoracic -- pathology
- Carcinoma 256, Walker -- blood supply
- Cell Movement
- Cells, Cultured
- Drug Screening Assays, Antitumor
- Drug Synergism
- Female
- Fingolimod Hydrochloride
- Indoles -- administration & dosage
- Male
- Mammary Neoplasms, Experimental -- blood supply
- Myocytes, Smooth Muscle -- drug effects
- Neoplasm Transplantation
- Propylene Glycols -- administration & dosage
- Proto-Oncogene Proteins c-sis -- pharmacology
- Pyrroles -- administration & dosage
- Rats
- Rats, Sprague-Dawley
- Receptor, Platelet-Derived Growth Factor beta -- antagonists & inhibitors
- Receptors, Lysosphingolipid -- metabolism
- Sphingosine -- administration & dosage
- Sphingosine-1-Phosphate Receptors
- Statistics, Nonparametric
- Sunitinib
- Tumor Burden -- drug effects
- Tyrphostins -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.